Cargando…
In-vitro susceptibility testing methods for the combination of ceftazidime-avibactam with aztreonam in metallobeta-lactamase producing organisms: Role of combination drugs in antibiotic resistance era
Resistance in Gram-negative organisms has become one of the leading threats in recent years. Of the different mechanisms described in the literature, resistance due to beta-lactamases genes have been overcomed by the use of a beta-lactamase inhibitor in combination with a beta-lactam antibiotic. Whe...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204069/ https://www.ncbi.nlm.nih.gov/pubmed/35715617 http://dx.doi.org/10.1038/s41429-022-00537-3 |
_version_ | 1784728834332950528 |
---|---|
author | Sreenivasan, Priya Sharma, Bhawna Kaur, Satinder Rana, Sudesh Biswal, Manisha Ray, Pallab Angrup, Archana |
author_facet | Sreenivasan, Priya Sharma, Bhawna Kaur, Satinder Rana, Sudesh Biswal, Manisha Ray, Pallab Angrup, Archana |
author_sort | Sreenivasan, Priya |
collection | PubMed |
description | Resistance in Gram-negative organisms has become one of the leading threats in recent years. Of the different mechanisms described in the literature, resistance due to beta-lactamases genes have been overcomed by the use of a beta-lactamase inhibitor in combination with a beta-lactam antibiotic. When this combination is insufficient to counter metallo-beta-lactamases, a third antibiotic, has been added to restore susceptibility. One such recent combination is ceftazidime-avibactam with aztreonam. In this study, 60 isolates of multidrug-resistant organisms producing metallo-beta-lactamases were included to perform in-vitro antibiotic susceptibility testing against ceftazidime-avibactam and aztreonam alone and in combination using three different methods. Individual testing revealed 100% (60/60) resistance to both ceftazidime-avibactam and aztreonam in all the isolates. The disk diffusion method showed an inhibition zone size of 21 mm in all the isolates, with 16 isolates showing an increase in inhibition zone size of >16 mm. In the E-test fixed ratio method, MICs of ceftazidime-avibactam and aztreonam when used alone ranged from 8/4 µg l(−1) to ≥256/4 µg l(−1) and 16 µg l(−1) to 256 µg l(−1), respectively, but in combination, these MICs were reduced to 0.016/4 µg l(−1) to 2/4 µg l(−1) with FIC < 0.5 in all the isolates. Similar results were obtained with the E-test agar dilution method with more than a 16-fold reduction in MIC in all the isolates when avibactam concentration was fixed at 4 µg l(−1). All three methods showed a 100% correlation with each other. The current study depicted the usefulness of combining ceftazidime-avibactam with aztreonam against organisms producing metallo-beta-lactamases and that disk diffusion methods can be used as a method for performing in-vitro antibiotic susceptibility testing of this combination. |
format | Online Article Text |
id | pubmed-9204069 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-92040692022-06-17 In-vitro susceptibility testing methods for the combination of ceftazidime-avibactam with aztreonam in metallobeta-lactamase producing organisms: Role of combination drugs in antibiotic resistance era Sreenivasan, Priya Sharma, Bhawna Kaur, Satinder Rana, Sudesh Biswal, Manisha Ray, Pallab Angrup, Archana J Antibiot (Tokyo) Article Resistance in Gram-negative organisms has become one of the leading threats in recent years. Of the different mechanisms described in the literature, resistance due to beta-lactamases genes have been overcomed by the use of a beta-lactamase inhibitor in combination with a beta-lactam antibiotic. When this combination is insufficient to counter metallo-beta-lactamases, a third antibiotic, has been added to restore susceptibility. One such recent combination is ceftazidime-avibactam with aztreonam. In this study, 60 isolates of multidrug-resistant organisms producing metallo-beta-lactamases were included to perform in-vitro antibiotic susceptibility testing against ceftazidime-avibactam and aztreonam alone and in combination using three different methods. Individual testing revealed 100% (60/60) resistance to both ceftazidime-avibactam and aztreonam in all the isolates. The disk diffusion method showed an inhibition zone size of 21 mm in all the isolates, with 16 isolates showing an increase in inhibition zone size of >16 mm. In the E-test fixed ratio method, MICs of ceftazidime-avibactam and aztreonam when used alone ranged from 8/4 µg l(−1) to ≥256/4 µg l(−1) and 16 µg l(−1) to 256 µg l(−1), respectively, but in combination, these MICs were reduced to 0.016/4 µg l(−1) to 2/4 µg l(−1) with FIC < 0.5 in all the isolates. Similar results were obtained with the E-test agar dilution method with more than a 16-fold reduction in MIC in all the isolates when avibactam concentration was fixed at 4 µg l(−1). All three methods showed a 100% correlation with each other. The current study depicted the usefulness of combining ceftazidime-avibactam with aztreonam against organisms producing metallo-beta-lactamases and that disk diffusion methods can be used as a method for performing in-vitro antibiotic susceptibility testing of this combination. Nature Publishing Group UK 2022-06-17 2022 /pmc/articles/PMC9204069/ /pubmed/35715617 http://dx.doi.org/10.1038/s41429-022-00537-3 Text en © The Author(s), under exclusive licence to the Japan Antibiotics Research Association 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Sreenivasan, Priya Sharma, Bhawna Kaur, Satinder Rana, Sudesh Biswal, Manisha Ray, Pallab Angrup, Archana In-vitro susceptibility testing methods for the combination of ceftazidime-avibactam with aztreonam in metallobeta-lactamase producing organisms: Role of combination drugs in antibiotic resistance era |
title | In-vitro susceptibility testing methods for the combination of ceftazidime-avibactam with aztreonam in metallobeta-lactamase producing organisms: Role of combination drugs in antibiotic resistance era |
title_full | In-vitro susceptibility testing methods for the combination of ceftazidime-avibactam with aztreonam in metallobeta-lactamase producing organisms: Role of combination drugs in antibiotic resistance era |
title_fullStr | In-vitro susceptibility testing methods for the combination of ceftazidime-avibactam with aztreonam in metallobeta-lactamase producing organisms: Role of combination drugs in antibiotic resistance era |
title_full_unstemmed | In-vitro susceptibility testing methods for the combination of ceftazidime-avibactam with aztreonam in metallobeta-lactamase producing organisms: Role of combination drugs in antibiotic resistance era |
title_short | In-vitro susceptibility testing methods for the combination of ceftazidime-avibactam with aztreonam in metallobeta-lactamase producing organisms: Role of combination drugs in antibiotic resistance era |
title_sort | in-vitro susceptibility testing methods for the combination of ceftazidime-avibactam with aztreonam in metallobeta-lactamase producing organisms: role of combination drugs in antibiotic resistance era |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204069/ https://www.ncbi.nlm.nih.gov/pubmed/35715617 http://dx.doi.org/10.1038/s41429-022-00537-3 |
work_keys_str_mv | AT sreenivasanpriya invitrosusceptibilitytestingmethodsforthecombinationofceftazidimeavibactamwithaztreonaminmetallobetalactamaseproducingorganismsroleofcombinationdrugsinantibioticresistanceera AT sharmabhawna invitrosusceptibilitytestingmethodsforthecombinationofceftazidimeavibactamwithaztreonaminmetallobetalactamaseproducingorganismsroleofcombinationdrugsinantibioticresistanceera AT kaursatinder invitrosusceptibilitytestingmethodsforthecombinationofceftazidimeavibactamwithaztreonaminmetallobetalactamaseproducingorganismsroleofcombinationdrugsinantibioticresistanceera AT ranasudesh invitrosusceptibilitytestingmethodsforthecombinationofceftazidimeavibactamwithaztreonaminmetallobetalactamaseproducingorganismsroleofcombinationdrugsinantibioticresistanceera AT biswalmanisha invitrosusceptibilitytestingmethodsforthecombinationofceftazidimeavibactamwithaztreonaminmetallobetalactamaseproducingorganismsroleofcombinationdrugsinantibioticresistanceera AT raypallab invitrosusceptibilitytestingmethodsforthecombinationofceftazidimeavibactamwithaztreonaminmetallobetalactamaseproducingorganismsroleofcombinationdrugsinantibioticresistanceera AT angruparchana invitrosusceptibilitytestingmethodsforthecombinationofceftazidimeavibactamwithaztreonaminmetallobetalactamaseproducingorganismsroleofcombinationdrugsinantibioticresistanceera |